Votrient 400 mg Tablet

उत्पाद विवरण

Votrient 400 mg Tablet is a targeted therapy classified as a tyrosine kinase inhibitor, primarily indicated for the treatment of advanced kidney cancer and soft tissue sarcoma (STS), which affects the body's soft tissues like muscles and fat. This medication works by blocking certain proteins that contribute to cancer cell growth and proliferation, thereby helping to slow down or stop tumor progression. It is important to note that the safety and effectiveness of Votrient in pediatric patients aged 2 to 18 years have not been established, making it crucial for healthcare providers to evaluate treatment options carefully in younger populations. Patients may experience side effects, including fatigue, nausea, and high blood pressure, which should be monitored closely by a healthcare professional. Regular follow-ups are essential to ensure optimal management of potential adverse effects while undergoing treatment with Votrient. As with any medication, patients should discuss their medical history and any ongoing treatments with their doctor to avoid interactions and ensure safety. Overall, Votrient 400 mg Tablet represents a vital option for those battling specific types of cancer, providing hope and a potential pathway toward improved health outcomes.